Swiss National Bank
CALA

Swiss National Bank’s Calithera Biosciences, Inc CALA Stock Holding History

Swiss National Bank’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,985
Closed -$290K – 2657
2021
Q1 		$290K Hold
5,985
– – ﹤0.01% 2474
2020
Q4 		$588K Hold
5,985
– – ﹤0.01% 2435
2020
Q3 		$413K Buy
5,985
+570
+11% +$49.7K ﹤0.01% 2384
2020
Q2 		$572K Buy
+5,415
New +$643K ﹤0.01% 2351
2018
Q2 		– Sell
-2,265
Closed -$285K – 2540
2018
Q1 		$285K Hold
2,265
– – ﹤0.01% 2462
2017
Q4 		$378K Buy
+2,265
New +$580K ﹤0.01% 2462

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss National Bank's CALA Position: Q2 2021 in Review

Swiss National Bank sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 5,985 shares — an estimated $290K sold.

Swiss National Bank first reported a position in CALA in Q4 2017 and held it in 6 quarters. The position peaked at $588K in Q4 2020. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Swiss National Bank reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Swiss National Bank sold 5,985 Calithera Biosciences, Inc shares in Q2 2021, an estimated $290K.
  • Swiss National Bank first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 6 quarters.
  • Swiss National Bank's Calithera Biosciences, Inc position peaked at $588K in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.